首页> 美国卫生研究院文献>The Journal of Biological Chemistry >The Nucleotide-binding State of Microtubules Modulates Kinesin Processivity and the Ability of Tau to Inhibit Kinesin-mediated Transport
【2h】

The Nucleotide-binding State of Microtubules Modulates Kinesin Processivity and the Ability of Tau to Inhibit Kinesin-mediated Transport

机译:微管的核苷酸结合状态调节驱动蛋白的持续能力和Tau抑制驱动蛋白介导的运输的能力。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The ability of Tau to act as a potent inhibitor of kinesin's processive run length in vitro suggests that it may actively participate in the regulation of axonal transport in vivo. However, it remains unclear how kinesin-based transport could then proceed effectively in neurons, where Tau is expressed at high levels. One potential explanation is that Tau, a conformationally dynamic protein, has multiple modes of interaction with the microtubule, not all of which inhibit kinesin's processive run length. Previous studies support the hypothesis that Tau has at least two modes of interaction with microtubules, but the mechanisms by which Tau adopts these different conformations and their functional consequences have not been investigated previously. In the present study, we have used single molecule imaging techniques to demonstrate that Tau inhibits kinesin's processive run length in an isoform-dependent manner on GDP-microtubules stabilized with either paclitaxel or glycerol/DMSO but not guanosine-5′-((α,β)-methyleno)triphosphate (GMPCPP)-stabilized microtubules. Furthermore, the order of Tau addition to microtubules before or after polymerization has no effect on the ability of Tau to modulate kinesin motility regardless of the stabilizing agent used. Finally, the processive run length of kinesin is reduced on GMPCPP-microtubules relative to GDP-microtubules, and kinesin's velocity is enhanced in the presence of 4-repeat long Tau but not the 3-repeat short isoform. These results shed new light on the potential role of Tau in the regulation of axonal transport, which is more complex than previously recognized.
机译:Tau在体外可作为驱动蛋白的持续性游走长度的有效抑制剂,这表明它可能在体内积极参与轴突运输的调节。但是,目前尚不清楚基于驱动蛋白的转运如何在高表达Tau的神经元中有效地进行。一种潜在的解释是,构象动态蛋白Tau具有与微管相互作用的多种模式,但并非所有模式都抑制驱动蛋白的持续运行长度。先前的研究支持Tau与微管具有至少两种相互作用模式的假设,但是Tau采用这些不同构象的机制及其功能后果尚未得到研究。在本研究中,我们已使用单分子成像技术来证明Tau对紫杉醇或甘油/ DMSO而不是鸟苷5'-((α, β)-甲基烯丙基三磷酸(GMPCPP)稳定的微管。此外,无论使用何种稳定剂,在聚合之前或之后向微管中添加Tau的顺序对Tau调节驱动蛋白运动性的能力均没有影响。最后,相对于GDP-微管,GMPCPP-微管的驱动蛋白的持续运行长度减少,并且在存在4-重复长Tau但不存在3-重复短同工型的情况下,驱动蛋白的速度得以提高。这些结果为Tau在调节轴突运输中的潜在作用提供了新的线索,该作用比以前公认的更为复杂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号